Further research revealed that miR-124, which is significantly downregulated in breast cancer bone metastases, inhibits osteoclastogenesis and suppresses bone metastasis through direct targeting of its downstream gene, IL-11 (Cai et al., 2018). Here, IL11 is linked to breast carcinoma.